These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20214477)

  • 41. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnosis and short-term therapeutic effect of AIDS complicated by tuberculosis].
    Zheng XM; Li SM
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1308-10. PubMed ID: 15567790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Managements of tuberculosis complicated with HIV infection and AIDS].
    Xiao H; He G
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):659-62. PubMed ID: 11225028
    [No Abstract]   [Full Text] [Related]  

  • 44. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection.
    Das VN; Pandey K; Kumar N; Hassan SM; Bimal S; Lal CS; Siddiqui NA; Bhattacharya SK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):18-21. PubMed ID: 16771207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
    HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measles outbreak in an orphanage: HIV-infected children on antiretroviral therapy are still at risk.
    Aurpibul L; Puthanakit T; Kanjanavanit S; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2010 Feb; 29(2):167-9. PubMed ID: 19907357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy.
    Saulsbury F
    Clin Infect Dis; 2001 Feb; 32(3):464-8. PubMed ID: 11170955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiretroviral Therapy in HIV-Infected Children With Tuberculosis: A Systematic Review.
    Sulis G; Amadasi S; Odone A; Penazzato M; Matteelli A
    Pediatr Infect Dis J; 2018 May; 37(5):e117-e125. PubMed ID: 28902004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Translational medicine as implementation science in the field of monitoring HIV and TB. New concepts emanating from resource-poor countries.
    Janossy G; Mandy F
    Cytometry B Clin Cytom; 2010 May; 78(3):183-7. PubMed ID: 20419763
    [No Abstract]   [Full Text] [Related]  

  • 50. [Miliary pattern in an HIV infected patient on tuberculostatic therapy. Paradoxical reaction of tuberculosis during antiretroviral therapy].
    del Pino Cuadrado J; Racionero Casero MA; Artacho Tejederas JR; Colomina Avilés J
    Rev Clin Esp; 2001 Apr; 201(4):219-20. PubMed ID: 11447912
    [No Abstract]   [Full Text] [Related]  

  • 51. Diagnostic 'nightmares' in an HIV patient with a cardiac mass and a previous history of tuberculosis.
    Pradegan N; Rossi E; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2019 Dec; 20(12):841-843. PubMed ID: 31464799
    [No Abstract]   [Full Text] [Related]  

  • 52. Tuberculosis drug development: ensuring people living with HIV are not left behind.
    Luetkemeyer AF; Getahun H; Chamie G; Lienhardt C; Havlir DV
    Am J Respir Crit Care Med; 2011 Nov; 184(10):1107-13. PubMed ID: 21868507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Balancing the upside and downside of antiretroviral therapy in children.
    Yogev R
    JAMA; 2005 May; 293(18):2272-4. PubMed ID: 15886383
    [No Abstract]   [Full Text] [Related]  

  • 54. Optimal treatment of Codisease due to HIV and tuberculosis.
    von Reyn CF
    J Infect Dis; 2011 Sep; 204(6):817-9. PubMed ID: 21849277
    [No Abstract]   [Full Text] [Related]  

  • 55. Pel-Ebstein cyclic fever: not just lymphoma.
    Schattner A; Keshet N
    Am J Med; 2010 Jul; 123(7):e3. PubMed ID: 20609672
    [No Abstract]   [Full Text] [Related]  

  • 56. Optimal timing of antiretroviral therapy initiation in patients coinfected with HIV and tuberculosis.
    Kiertiburanakul S; Manosuthi W; Sungkanuparph S
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):143-6. PubMed ID: 22115397
    [No Abstract]   [Full Text] [Related]  

  • 57. [The clinical and morphological features of the course of tuberculosis in HIV infection].
    Kornilova SKh; Ziuzia IuR; Alekseeva LP; Parkhomenko IuG; Erokhin VV
    Probl Tuberk Bolezn Legk; 2008; (10):13-20. PubMed ID: 19069186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.
    Srikantiah P; Wong JK; Liegler T; Walusimbi M; Mayanja-Kizza H; Kayanja HK; Mugerwa RD; Charlebois ED; Boom WH; Whalen CC; Havlir DV
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):458-60. PubMed ID: 19011423
    [No Abstract]   [Full Text] [Related]  

  • 59. Time for men to count, too.
    Horton KC; Houben RM; White RG; Corbett EL
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):425. PubMed ID: 27046729
    [No Abstract]   [Full Text] [Related]  

  • 60. Update in tuberculosis 2007.
    Yew WW; Leung CC
    Am J Respir Crit Care Med; 2008 Mar; 177(5):479-85. PubMed ID: 18296469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.